Delmont Laboratories, Inc. is a privately held company with its core focus in developing products that treat staphylococcal skin infection. We are committed to ongoing research to better understand and develop treatments for this condition and to protect dogs from recurrence and ensuing methicillin-resistant bacteria. Our product Staphage Lysate (SPL)® has proven highly effective in providing long-term control of this resistant condition. It is unique in that it is a whole bacterial cell preparation from common virulent Staph strains that have been solubilized through the use of polyvalent staphylococcal bacteriophage.